Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Mira Pharmaceuticals Inc increased its cash reserves by 1,211.35%, or 4.25m. Cash Flow from Financing totalled 8.78m or -- of revenues. In addition the company used 4.53m for operations while cash used for investing totalled .
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.1501 |
---|---|
Tangible book value per share | 0.1501 |
More ▼
Balance sheet in USDView more
Current ratio | 3.68 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼